Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer
Open Access
- 12 September 2011
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 171 (16), 1487-1493
- https://doi.org/10.1001/archinternmed.2011.356
Abstract
Kidney cancer is the seventh leading type of cancer among men and the ninth among women in the United States.1 Renal cell cancer (RCC) is the most common type of kidney cancer, accounting for 85% of all cases. The incidence of RCC has been rising in the United States and worldwide.2 Smoking, obesity, and hypertension are established modifiable risk factors.Keywords
This publication has 35 references indexed in Scilit:
- Indomethacin causes renal epithelial cell injury involving Mcl-1 down-regulationBiochemical and Biophysical Research Communications, 2009
- Use of Prescription and Over-the-counter Medications and Dietary Supplements Among Older Adults in the United StatesJAMA, 2008
- A Population-Based Cohort Study of Mortality Among Users of Ibuprofen in DenmarkClinical Journal of Sport Medicine, 2004
- Acetaminophen and Renal and Bladder CancerEpidemiology, 1996
- International renal‐cell cancer study. II. AnalgesicsInternational Journal of Cancer, 1995
- International renal‐cell cancer study. III. Role of weight, height, physical activity, and use of amphetaminesInternational Journal of Cancer, 1995
- Use of analgesics and risk of renal cell cancerInternational Journal of Cancer, 1994
- Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvisInternational Journal of Cancer, 1993
- Analgesic nephropathy in fischer 344 rats: comparative effects of chronic treatment with either aspirin or paracetamolPathology, 1991
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986